In 2024, the CEO of Novo Nordisk took a reduction in wages of $ 1.5 million than the share price of the pharmaceutical tank and it missed profit and dei goals. Read more
Source link

In 2024, the CEO of Novo Nordisk took a reduction in wages of $ 1.5 million than the share price of the pharmaceutical tank and it missed profit and dei goals. Read more
Source link